about
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparumAnimal models for photodynamic therapy (PDT)Functionalized fullerenes in photodynamic therapyNeurosurgical confocal endomicroscopy: A review of contrast agents, confocal systems, and future imaging modalitiesCan nanotechnology potentiate photodynamic therapy?In vivo curative and protective potential of orally administered 5-aminolevulinic acid plus ferrous ion against malaria.Effects of 5-aminolevulinic acid-mediated sonodynamic therapy on macrophagesInnovative therapy of cutaneous T-cell lymphoma: beyond psoralen and ultraviolet light and nitrogen mustardPreferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypesSurgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival.Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acid-based photodynamic therapy.δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancyFluorescence detection and depletion of T47D breast cancer cells from human mononuclear cell-enriched blood preparations by photodynamic treatment: Basic in vitro experiments towards the removal of circulating tumor cells.New approaches to gastric cancer staging: beyond endoscopic ultrasound, computed tomography and positron emission tomography.Rapid upregulation of cytoprotective nitric oxide in breast tumor cells subjected to a photodynamic therapy-like oxidative challengeAutofluorescence spectroscopy and imaging: a tool for biomedical research and diagnosisExpression of murine 5-aminolevulinate synthase variants causes protoporphyrin IX accumulation and light-induced mammalian cell deathInhibition of VDAC1 prevents Ca²⁺-mediated oxidative stress and apoptosis induced by 5-aminolevulinic acid mediated sonodynamic therapy in THP-1 macrophages.The effect of iron ion on the specificity of photodynamic therapy with 5-aminolevulinic acid.Aminolevulinic acid-mediated photodynamic therapy of human meningioma: an in vitro study on primary cell lines.Fluorescence characteristics of human Barrett tissue specimens grafted on chick chorioallantoic membrane.Hyperthermotherapy enhances antitumor effect of 5-aminolevulinic acid-mediated sonodynamic therapy with activation of caspase-dependent apoptotic pathway in human glioma.New photosensitizers for photodynamic therapyOptical technologies for intraoperative neurosurgical guidance.Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy.Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy.Stable synthetic bacteriochlorins for photodynamic therapy: role of dicyano peripheral groups, central metal substitution (2H, Zn, Pd), and Cremophor EL delivery.Real-time multi-modality imaging of glioblastoma tumor resection and recurrence.Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling.Interference with the Jaffé method for creatinine following 5-aminolevulinic acid administration.The proton-coupled oligopeptide transporter 1 plays a major role in the intestinal permeability and absorption of 5-aminolevulinic acidA Nanosystem Capable of Releasing a Photosensitizer Bioprecursor under Two-Photon Irradiation for Photodynamic Therapy.Photodynamic Therapy for Cancer and for Infections: What Is the Difference?Image-guided resection of malignant gliomas using fluorescent nanoparticles.Biological detection by optical oxygen sensing.Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro.The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review.On the in vivo photochemical rate parameters for PDT reactive oxygen species modeling.Photodynamic therapy with the novel photosensitizer chlorophyllin f induces apoptosis and autophagy in human bladder cancer cells.Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy.
P2860
Q22061870-EADC7F40-1F1B-46D4-A953-747043A10317Q26785484-AA1F9141-76EE-40B6-A799-1681456031A0Q26851870-9EF5D41E-4E53-424A-A4E1-696DAC3BA6F6Q26991506-2A505682-258D-46BA-A1A8-9A583229736BQ28388084-4BE3B8BF-70D1-4D2A-A4A7-3CCBA04C0123Q30386961-ABFA8F21-508B-4E09-96A5-1A09BDC3DFA1Q30458115-B53BE7E9-A6AC-48D5-AA85-84E14BD34789Q33590400-0D455C40-04A4-4BC9-840E-645DEC97F129Q33731681-9781959C-BA06-4DDF-B44A-927E390F6E2EQ33732828-2464AE94-6F97-4B4F-8605-2A41C05F0673Q33798289-4E30F72B-3DB1-4DFB-B479-3766027A823DQ33974708-B422E39E-03C5-41A3-BE49-532AFD51A322Q34068114-F5A8A9F8-93EC-4968-9B0C-DED80D0E9883Q34326622-31D57409-4FA1-4FF4-97A4-146EB82F944FQ34625262-FFAC2171-433D-4927-A481-317876423141Q34905540-801B2B25-0938-404E-93B9-F03C98CF377BQ35143756-5749C207-BB93-4F45-821B-58E8516FD3A9Q35363771-8C579BFE-BC18-479B-AFBD-BF60AC0BC405Q35590305-1A925510-D6AA-4F12-8A94-45BC9B9DBD11Q35622314-9B37C607-25E8-4848-8B8D-2769D6838540Q35861309-6ADB98BD-1968-4DF2-BB61-82F1F59C98A2Q35914670-A1414126-8875-45FE-B30B-D66E63E85CA0Q35919257-D95DC55A-BEAD-433D-88A2-C804706ED149Q35939478-7D0BACA2-AF83-4F2F-A653-22546243A376Q36009115-75C79934-CF22-4F46-83A5-1D4FF34A2D89Q36271147-7ADF5EF5-B841-4CC4-8CE6-14FDAD19A1BDQ36458544-94CF5E0E-3A1B-407D-A096-91C3109380AAQ36543537-0091688D-8809-4B08-80FA-2FC99629A35BQ36627008-F2787099-DED2-44FF-9C1E-645F47F4C178Q36687585-0231B5F2-043D-471A-A07A-1F14684AD3C9Q36744197-ED627D88-8D19-47BF-997F-3EB429FBE18DQ37337384-8826EB42-5632-43AC-9B59-3D9FBAE50015Q38068168-B7E27599-5852-4657-8BB3-622051FE17F2Q38078875-23B9A61E-B125-4EEF-A6CF-83879A2F4C62Q38115186-0E1E3294-9790-4F5D-8107-39B8057689B8Q38617563-6AC74579-BC29-4058-83CD-05C08C20DA38Q38713218-7BC001CF-457A-4F6D-8A5C-1563225E0569Q38976558-44249B17-9A76-402E-8967-484D76174031Q39030439-F64B15E6-21A0-41B0-B2A7-073B691AB0FCQ39179209-5E6B1BA3-A0D4-4F7A-AE73-26A8C92B7D27
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ALA and its clinical impact, from bench to bedside.
@en
ALA and its clinical impact, from bench to bedside.
@nl
type
label
ALA and its clinical impact, from bench to bedside.
@en
ALA and its clinical impact, from bench to bedside.
@nl
prefLabel
ALA and its clinical impact, from bench to bedside.
@en
ALA and its clinical impact, from bench to bedside.
@nl
P2860
P356
P1476
ALA and its clinical impact, from bench to bedside.
@en
P2093
Barbara Krammer
Kristjan Plaetzer
P2860
P304
P356
10.1039/B712847A
P577
2007-12-07T00:00:00Z